Ansbert Gadicke
Director, Pharmasset Inc.
Companies
- TCR2 THERAPEUTICS INC.Board member Feb 13, 2019 to Jun 5, 20231
- Kalaris Therapeutics, Inc.Board member Jul 29, 2020 to Aug 1, 20222
- Cullinan OncologyBoard member Jan 7, 2021 to Jun 23, 20223
- iTeos Therapeutics, Inc.Board member Jul 23, 2020 to Oct 21, 20204
- Radius Health, Inc.Board member May 19, 2011 to Feb 22, 20175
- Chiasma (United States)Board member Jul 15, 2015 to Jun 13, 20166
- Verastem OncologyBoard member Jan 26, 2012 to Mar 8, 20127
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Cullinan Oncology CGEM8,243,757 shares8$112.8M at $13.68Feb 10, 2023
- Kalaris Therapeutics, Inc. KLRS16,704,963 shares9$31.9M at $1.91Aug 1, 2022
- TCR2 THERAPEUTICS INC.0 shares10Jun 1, 2023
- iTeos Therapeutics, Inc.4,484,728 shares11Jan 5, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 12, 2026Bought 1,112,777 shares at $18.00 of Aktis Oncology, Inc.12
- Jan 12, 2026Converted 1,577,119 shares of Aktis Oncology, Inc.12
- Jan 12, 2026Converted 5,914,197 shares of Aktis Oncology, Inc.12
- Jan 12, 2026Converted 1,314,262 shares of Aktis Oncology, Inc.12
- Jun 1, 2023Other 3,370,982 shares of TCR2 THERAPEUTICS INC.10
- Jun 1, 2023Other 3,854,963 shares of TCR2 THERAPEUTICS INC.10
- Jun 1, 2023Other 304,001 shares of TCR2 THERAPEUTICS INC.10
- May 22, 2023Sold 70,170 shares at $1.88 of TCR2 THERAPEUTICS INC.13
- May 22, 2023Exercised 178,269 shares at $0.74 of TCR2 THERAPEUTICS INC.13
- Jul 28, 2022Granted 3,253,796 shares at $4.61 of Kalaris Therapeutics, Inc.9
- Jan 5, 2022Sold 30,347 shares at $42.03 of iTeos Therapeutics, Inc.11
- Jan 4, 2022Sold 12,829 shares at $46.47 of iTeos Therapeutics, Inc.11
- Jan 4, 2022Sold 11,318 shares at $45.32 of iTeos Therapeutics, Inc.11
- Jan 4, 2022Sold 32,396 shares at $43.20 of iTeos Therapeutics, Inc.11
- Jan 4, 2022Sold 158,579 shares at $42.05 of iTeos Therapeutics, Inc.11
- Dec 21, 2021Exercised options 350,938 shares at $4.30 of Cullinan Oncology8
- Oct 14, 2021Sold 45,719 shares at $27.30 of iTeos Therapeutics, Inc.14
- Oct 13, 2021Sold 35,023 shares at $27.13 of iTeos Therapeutics, Inc.14
- Oct 12, 2021Sold 14,260 shares at $27.09 of iTeos Therapeutics, Inc.14
- Oct 4, 2021Sold 34,659 shares at $27.06 of iTeos Therapeutics, Inc.15
- Oct 1, 2021Sold 11,471 shares at $27.00 of iTeos Therapeutics, Inc.15
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARTCR2 THERAPEUTICS INC., Board member
- 2
- 3SEC EDGARCullinan Oncology, Board member
- 4
- 5SEC EDGARRadius Health, Inc., Board member
- 6
- 7SEC EDGARVerastem Oncology, Board member
- 8
- 9
- 10
- 11
- 12SEC EDGARForm 4 filed Jan 14, 2026
- 13SEC EDGARForm 4 filed May 24, 2023
- 14SEC EDGARForm 4 filed Oct 14, 2021
- 15SEC EDGARForm 4 filed Oct 5, 2021